Catheter Precision Inc. (AMEX:VTAK) price on Wednesday, October 23, fall -12.77% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $0.79.
A look at the stock’s price movement, the close in the last trading session was $0.91, moving within a range at $0.7717 and $0.8796. Turning to its 52-week performance, $8.40 and $0.31 were the 52-week high and 52-week low respectively. Overall, VTAK moved 49.01% over the past month.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Catheter Precision Inc.’s market cap currently stands at around $2.22 million, with investors looking forward to this quarter’s earnings report slated for in November.
Analysts have a consensus estimate of 1.06M for the company’s revenue for the quarter, with a low and high estimate of 1.06M and 1.06M respectively. The average forecast suggests up to a 697.00% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 3.19M, representing a 621.70% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that VTAK is a 50% Sell. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
VTAK’s current price about 66.31% and 1.48% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 60.84, while 7-day volatility ratio is 33.13% and 17.56% in the 30-day chart. Further, Catheter Precision Inc. (VTAK) has a beta value of -0.35, and an average true range (ATR) of 0.16.
If we refocus on Catheter Precision Inc. (AMEX:VTAK), historical trading data shows that trading volumes averaged 20.31 over the past 10 days and 3.31 million over the past 3 months. The company’s latest data on shares outstanding shows there are 2.80 million shares.
The 14.18% of Catheter Precision Inc.’s shares are in the hands of company insiders while institutional holders own 2.54% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 46547.0 on 2024-09-30, giving us a short ratio of 0.1. The data shows that as of 2024-09-30 short interest in Catheter Precision Inc. (VTAK) stood at 172.0 of shares outstanding, with shares short falling to 0.17 million registered in 2024-08-30. Current price change has pushed the stock -80.37% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the VTAK stock continues to rise going into the next quarter.
